Cervical Pessary for Prevention of Spontaneous Preterm Birth in Singleton Pregnancies With Arrested Preterm Labor
Launched by FEDERICO II UNIVERSITY · May 18, 2018
Trial Information
Current as of June 21, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton gestations
- • Diagnosis of arrested PTL
- • 18-50 years of age
- • TVU CL ≤25mm at the time of randomization
- Exclusion Criteria:
- • Multiple gestations
- • Rupture of membranes at the time of randomization
- • Known major fetal structural (i.e. defined as those that are lethal or require prenatal or postnatal surgery) or chromosomal abnormality
- • Fetal death at the time of randomization
- • Cerclage in situ at the time of randomization
- • Pessary in situ at the time of randomization
- • Vaginal bleeding at the time of randomization
- • Women who are unconscious, severly ill, mentally handicapped, or under the age of 18 years
- • Placenta previa and/or accreta
- • Ballooning of membranes outside the cervix into the vaginal or TVU CL = 0mm at the time of randomization
- • Painful and regular uterine contractions at the time of randomization
About Federico Ii University
Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials